Telemedicine-Delivered Prolonged Exposure Therapy for PTSD in People with Opioid Use Disorder
Official title: Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals with OUD
Funded at University of Vermont & St Agric College · NIH-11330257 · Data updated 2026-11-12
A new telemedicine-based therapy program aims to help adults with opioid use disorder who also have PTSD feel better and stay in treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project start | July 15, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $690,686 |
| NIH project number | 5R01DA057308-04 |
| Project ID | NIH-11330257 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years or older with opioid use disorder, PTSD symptoms, and access to telemedicine options, including those on buprenorphine maintenance.
✕Less likely to help
Individuals without PTSD symptoms or without access to telemedicine might not benefit.
What this research studies
This project tests a telemedicine version of Prolonged Exposure therapy to treat PTSD in adults who are on medication for opioid use disorder. It builds on previous findings that PE can help PTSD but attendance is a barrier, and that adding financial incentives may improve engagement. The study compares standard care, PE, and PE with attendance incentives, focusing on reducing PTSD symptoms and potentially reducing illicit drug use. Researchers will use a novel online platform to reach patients who may have limited access to in-person care. If successful, the approach could expand access to effective PTSD treatment for people with opioid use disorder.
Why it matters
Potential benefit: If successful, patients could experience reduced PTSD symptoms and better adherence to opioid-use treatment, potentially improving overall health and stability.
How similar studies have gone: Early data suggest that telemedicine-delivered PE with attendance incentives can improve therapy attendance and PTSD symptoms, warranting a definitive evaluation.
Where this research is happening
-
University of Vermont & St Agric College
Burlington, United States Active
Researchers
- Principal investigator: Peck, Kelly R. — University of Vermont & St Agric College
- Study coordinator: Peck, Kelly R.
Related research
Other NIH-funded projects on the same topics.
-
Telemedicine therapy for PTSD in people with opioid use disorder
This study is testing a new way to provide therapy for people dealing with both PTSD and opioid use issues through online sessions, making it easier for them to attend and get the help they need, while also seeing if offering rewards for attending sessions can improve their treatment experience.
-
Understanding how PTSD affects self-control and brain function
Researchers are studying how PTSD changes the brain’s control over thoughts and actions, and how this might affect Veterans’ daily lives and responses to treatment.
-
Improving after-hours pediatric care with a telemedicine and medicine-delivery tool using smart technology
A pediatric telemedicine and medication delivery service is being improved with smart tools to help kids get quick after-hours care, especially when a clinic is closed.
-
Ketamine to boost fear extinction and memory on PTSD patients
A study testing whether ketamine can help people with PTSD better relearn and forget fear when given in a guided treatment plan.
-
Treating PTSD and opioid use disorder in residential care with Written Exposure Therapy (WEST)
A short, patient-friendly plan to adapt a proven PTSD therapy for people with opioid use disorder in residential treatment and test its practicality and impact.
-
Dynamic PTSD-Related Cognitive Risk in Aging WTC Responders
This project follows World Trade Center responders as they age to understand how PTSD symptoms relate to changes in thinking skills over time.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.